Craig Newby is a dynamic R&D leader with extensive experience in the pharmaceuticals and consumer healthcare sectors. Currently serving as the Head of Emerging Markets R&D at Abbott, Craig focuses on developing new products for the APAC, METAP, Russia, and China regions. Previously, Craig held various key positions at companies such as GlaxoSmithKline and Mundipharma, where they demonstrated expertise in product innovation, analytical strategy, and team leadership. Craig earned a PhD in Dermatology from King's College London and is known for their strong scientific and ethical judgment, as well as their ability to build high-performance teams.
This person is not in the org chart
This person is not in any teams
This person is not in any offices